• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基质辅助激光解吸电离质谱法研究抗病毒抑制剂与流感神经氨酸酶的结合。

Anti-viral inhibitor binding to influenza neuraminidase by MALDI mass spectrometry.

机构信息

School of Molecular Bioscience, University of Sydney, Sydney, NSW 2006, Australia.

出版信息

Anal Chem. 2012 Apr 17;84(8):3725-30. doi: 10.1021/ac300291c. Epub 2012 Mar 28.

DOI:10.1021/ac300291c
PMID:22409142
Abstract

A matrix-assisted laser desorption ionization (MALDI) mass spectrometry-based approach is applied to identify active site domains within influenza neuraminidase that bind the antiviral inhibitors zanamivir (ZANA) and 2-deoxy-2,3-didehydro-N-acetylneuraminic acid (DANA). Combined data from the tryptic and Glu-C endoproteinase digests of neuraminidase-inhibitor complexes have identified binding peptides that contain the active site residues Arg118, Glu119, Arg156, Glu276, and Tyr406. The binding of these residues was confirmed from the analysis of available X-ray crystal structures. The ability to identify peptides within the active sites of proteins and likely binding residues provides both a rapid and relatively high throughput approach with which to screen protein-drug interactions by MALDI mass spectrometry.

摘要

基质辅助激光解吸电离(MALDI)质谱法被应用于鉴定流感神经氨酸酶中的活性位点结构域,这些结构域能够与抗病毒抑制剂扎那米韦(ZANA)和 2-脱氧-2,3-二脱氢-N-乙酰神经氨酸(DANA)结合。来自神经氨酸酶-抑制剂复合物的胰蛋白酶和 Glu-C 内切蛋白酶消化的综合数据,鉴定出了包含活性位点残基 Arg118、Glu119、Arg156、Glu276 和 Tyr406 的结合肽。这些残基的结合通过对现有 X 射线晶体结构的分析得到了证实。通过 MALDI 质谱法,能够在蛋白质的活性位点和可能的结合残基内鉴定出肽,这为筛选蛋白质-药物相互作用提供了一种快速且相对高通量的方法。

相似文献

1
Anti-viral inhibitor binding to influenza neuraminidase by MALDI mass spectrometry.基质辅助激光解吸电离质谱法研究抗病毒抑制剂与流感神经氨酸酶的结合。
Anal Chem. 2012 Apr 17;84(8):3725-30. doi: 10.1021/ac300291c. Epub 2012 Mar 28.
2
Three-dimensional structure of the complex of 4-guanidino-Neu5Ac2en and influenza virus neuraminidase.4-胍基-唾液酸烯丙酯与流感病毒神经氨酸酶复合物的三维结构
Protein Sci. 1995 Jun;4(6):1081-7. doi: 10.1002/pro.5560040606.
3
Molecular dynamics and free energy analysis of neuraminidase-ligand interactions.神经氨酸酶-配体相互作用的分子动力学与自由能分析
Protein Sci. 2004 Apr;13(4):946-57. doi: 10.1110/ps.03129704.
4
Analysis of inhibitor binding in influenza virus neuraminidase.流感病毒神经氨酸酶中抑制剂结合情况的分析
Protein Sci. 2001 Apr;10(4):689-96. doi: 10.1110/ps.41801.
5
Influenza neuraminidase operates via a nucleophilic mechanism and can be targeted by covalent inhibitors.流感神经氨酸酶通过亲核机制发挥作用,可被共价抑制剂靶向。
Nat Commun. 2013;4:1491. doi: 10.1038/ncomms2487.
6
A practical synthesis of zanamivir phosphonate congeners with potent anti-influenza activity.具有强大抗流感活性的扎那米韦膦酸盐同系物的实用合成。
J Am Chem Soc. 2011 Nov 9;133(44):17959-65. doi: 10.1021/ja207892q. Epub 2011 Oct 14.
7
A study of the active site of influenza virus sialidase: an approach to the rational design of novel anti-influenza drugs.流感病毒唾液酸酶活性位点的研究:新型抗流感药物合理设计的一种方法。
J Med Chem. 1996 Jan 19;39(2):388-91. doi: 10.1021/jm950294c.
8
Influenza virus neuraminidase: structure, antibodies, and inhibitors.流感病毒神经氨酸酶:结构、抗体与抑制剂
Protein Sci. 1994 Oct;3(10):1687-96. doi: 10.1002/pro.5560031007.
9
Docking and 3D-QSAR investigations of pyrrolidine derivatives as potent neuraminidase inhibitors.作为强效神经氨酸酶抑制剂的吡咯烷衍生物的对接和 3D-QSAR 研究。
Chem Biol Drug Des. 2012 May;79(5):863-8. doi: 10.1111/j.1747-0285.2012.01330.x. Epub 2012 Feb 15.
10
Mechanism-based inhibitors to probe transitional states of glycoside hydrolases.基于机制的抑制剂用于探究糖苷水解酶的过渡态。
Methods Enzymol. 2006;415:202-12. doi: 10.1016/S0076-6879(06)15013-2.

引用本文的文献

1
25 Years Responding to Respiratory and Other Viruses with Mass Spectrometry.25年来利用质谱技术应对呼吸道病毒及其他病毒
Mass Spectrom (Tokyo). 2023;12(1):A0136. doi: 10.5702/massspectrometry.A0136. Epub 2023 Dec 1.
2
Molecular basis of influenza hemagglutinin inhibition with an entry-blocker peptide by computational docking and mass spectrometry.通过计算对接和质谱分析研究一种进入阻断肽抑制流感血凝素的分子基础。
Antivir Chem Chemother. 2015 Aug;24(3-4):109-17. doi: 10.1177/2040206615622920. Epub 2016 Jan 12.
3
Targeting a cluster of arginine residues of neuraminidase to avoid oseltamivir resistance in influenza A (H1N1): a theoretical study.
靶向神经氨酸酶的一组精氨酸残基以避免甲型H1N1流感病毒对奥司他韦产生耐药性:一项理论研究。
J Mol Model. 2015 Jan;21(1):8. doi: 10.1007/s00894-014-2525-9. Epub 2015 Jan 22.
4
Screening of neuraminidase inhibitors from traditional Chinese medicine by transverse diffusion mediated capillary microanalysis.基于横向扩散介导毛细管微分析技术从中药中筛选神经氨酸酶抑制剂
Biomicrofluidics. 2014 Aug 27;8(5):052003. doi: 10.1063/1.4894162. eCollection 2014 Sep.
5
Influenza neuraminidase operates via a nucleophilic mechanism and can be targeted by covalent inhibitors.流感神经氨酸酶通过亲核机制发挥作用,可被共价抑制剂靶向。
Nat Commun. 2013;4:1491. doi: 10.1038/ncomms2487.